39 related articles for article (PubMed ID: 24795055)
1. Association of interferon-γ inducible protein-10 pretreatment level and sustained virological response in HCV-positive Egyptian patients.
Omran D; Hamdy S; Tawfik S; Esmat S; Saleh DA; Zayed RA
Ann Clin Lab Sci; 2014; 44(2):167-72. PubMed ID: 24795055
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment serum interferon gamma inducible protein-10 as biomarker of fibrosis and predictor of virological response in genotype 4 hepatitis C virus infection.
Khalifa KA; Radwan WM; Attallah KM; Hosney H; Eed EM
Acta Gastroenterol Belg; 2014 Dec; 77(4):401-7. PubMed ID: 25682629
[TBL] [Abstract][Full Text] [Related]
3. Interferon-γ-inducible protein-10 in chronic hepatitis C: Correlations with insulin resistance, histological features & sustained virological response.
Crisan D; Grigorescu MD; Radu C; Suciu A; Grigorescu M
Indian J Med Res; 2017 Apr; 145(4):543-550. PubMed ID: 28862188
[TBL] [Abstract][Full Text] [Related]
4. Adipokines and insulin resistance, predictors of response to therapy in Egyptian patients with chronic hepatitis C virus genotype 4.
Saad Y; Ahmed A; Saleh DA; Doss W
Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):920-5. PubMed ID: 23442415
[TBL] [Abstract][Full Text] [Related]
5. Serum inducible protein-10 chemokine as a biomarker for clearance of HCV with and without treatment in Egyptian patients.
Tabll A; El Shenawy R; Elsharkawy H; Mohamed FZ
Hum Antibodies; 2019; 27(4):265-273. PubMed ID: 31127759
[TBL] [Abstract][Full Text] [Related]
6. Presence of HCV-RNA after ultracentrifugation of serum samples during the follow-up of chronic hepatitis C patients with a sustained virological response may predict reactivation of hepatitis C virus infection.
Castillo I; Bartolomé J; Quiroga JA; Barril G; Carreño V
Aliment Pharmacol Ther; 2009 Sep; 30(5):477-86. PubMed ID: 19523175
[TBL] [Abstract][Full Text] [Related]
7. New proposal for response-guided peg-interferon-plus-ribavirin combination therapy for chronic hepatitis C virus genotype 2 infection.
Abe H; Aida Y; Ishiguro H; Yoshizawa K; Seki N; Miyazaki T; Itagaki M; Sutoh S; Ika M; Kato K; Shimada N; Tsubota A; Aizawa Y
J Med Virol; 2013 Sep; 85(9):1523-33. PubMed ID: 23775277
[TBL] [Abstract][Full Text] [Related]
8. Human leukocyte antigen class I alleles can predict response to pegylated interferon/ribavirin therapy in chronic hepatitis C Egyptian patients.
Farag RE; Arafa MM; El-Etreby S; Saudy NS; Eldeek BS; El-Alfy HA; Goda IF; Ali RM
Arch Iran Med; 2013 Feb; 16(2):68-73. PubMed ID: 23360626
[TBL] [Abstract][Full Text] [Related]
9. IP-10 predicts the first phase decline of HCV RNA and overall viral response to therapy in patients co-infected with chronic hepatitis C virus infection and HIV.
Falconer K; Askarieh G; Weis N; Hellstrand K; Alaeus A; Lagging M
Scand J Infect Dis; 2010 Dec; 42(11-12):896-901. PubMed ID: 20608766
[TBL] [Abstract][Full Text] [Related]
10. [The effects of individualized therapeutic programs on chronic hepatitis C and the influential factors of virological response].
Cheng ML; Wang J; Zeng AP; Liu XF
Zhonghua Nei Ke Za Zhi; 2012 Oct; 51(10):751-4. PubMed ID: 23290969
[TBL] [Abstract][Full Text] [Related]
11. [Measurement of hepatitis C virus RNA 12 weeks after treatment predicts sustained virological response in HIV-HCV co-infected patients].
Girón-González JA; Márquez MJ; Márquez M; Corchado S; Soto MJ; Martín-Aspas A; Montes De Oca M; Guerrero F; Fernández-Gutiérrez C
Enferm Infecc Microbiol Clin; 2012 Jan; 30(1):15-7. PubMed ID: 21908078
[TBL] [Abstract][Full Text] [Related]
12. Complete eradication of hepatitis C virus after interferon treatment for chronic hepatitis C.
De Mitri MS; Morsica G; Chen CH; Mele L; Baccarini P; Chianese R; Piccinini A; Lazzarin A; Pisi E
Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):255-61. PubMed ID: 9646218
[TBL] [Abstract][Full Text] [Related]
13. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
[TBL] [Abstract][Full Text] [Related]
14. Changes in the co-expressions of interleukin 29 (IL-29), IFN-inducible protein 10 (IP-10) and monokine induced by IFNγ (MIG) genes in chronic hepatitis C Egyptian patients untreated and treated with DAAs.
Gaballah A; Naga IS; Zaghloul MS; Mostafa HM; Noby A
Acta Virol; 2021; 65(2):141-148. PubMed ID: 34130465
[TBL] [Abstract][Full Text] [Related]
15. Changes in serum interferon-γ-inducible protein-10 levels and liver stiffness among chronic hepatitis C Egyptian patients in response to directly acting antiviral agents.
El-Nahaas SM; Rady NH; Malek S; Serag K
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e335-e340. PubMed ID: 33470694
[TBL] [Abstract][Full Text] [Related]
16. High urine IP-10 levels associate with chronic HCV infection.
Petrone L; Chiacchio T; Vanini V; Petruccioli E; Cuzzi G; Di Giacomo C; Pucci L; Montalbano M; Lionetti R; Testa A; Lapa D; Navarra A; Visco-Comandini U; Goletti D
J Infect; 2014 Jun; 68(6):591-600. PubMed ID: 24582930
[TBL] [Abstract][Full Text] [Related]
17. Relation between HLA-DP/DQ Polymorphisms, Serum IP-10 and Response to Direct Acting Antiviral Therapy among HCV Infected Patients.
Ghazy AA; Haydara T; Farooq UD; Nadwa EH; Ghazy HA; Amer I
Egypt J Immunol; 2020 Jan; 27(1):177-185. PubMed ID: 33236620
[TBL] [Abstract][Full Text] [Related]
18. Interferon γ-induced protein 10 kinetics in treatment-naive versus treatment-experienced patients receiving interferon-free therapy for hepatitis C virus infection: implications for the innate immune response.
Lin JC; Habersetzer F; Rodriguez-Torres M; Afdhal N; Lawitz EJ; Paulson MS; Zhu Y; Subramanian GM; McHutchison JG; Sulkowski M; Wyles DL; Schooley RT
J Infect Dis; 2014 Dec; 210(12):1881-5. PubMed ID: 24907384
[TBL] [Abstract][Full Text] [Related]
19. Serum IP-10 Levels Correlate with the Severity of Liver Histopathology in Patients Infected with Genotype-1 HCV.
You CR; Park SH; Jeong SW; Woo HY; Bae SH; Choi JY; Sung YC; Yoon SK
Gut Liver; 2011 Dec; 5(4):506-12. PubMed ID: 22195251
[TBL] [Abstract][Full Text] [Related]
20. The induction of the p53 tumor suppressor protein bridges the apoptotic and autophagic signaling pathways to regulate cell death in prostate cancer cells.
Ringer L; Sirajuddin P; Tricoli L; Waye S; Choudhry MU; Parasido E; Sivakumar A; Heckler M; Naeem A; Abdelgawad I; Liu X; Feldman AS; Lee RJ; Wu CL; Yenugonda V; Kallakury B; Dritschilo A; Lynch J; Schlegel R; Rodriguez O; Pestell RG; Avantaggiati ML; Albanese C
Oncotarget; 2014 Nov; 5(21):10678-91. PubMed ID: 25296977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
